| Name | Title | Contact Details |
|---|
Avaxia is a leader in the growing field of gut-targeted therapeutics — orally administered, minimally absorbed drugs that are designed to act locally in the gastrointestinal tract. Avaxia’s lead clinical candidate, AVX-470, is an oral anti-TNF antibody for inflammatory bowel disease. This transformative product offers potentially improved safety and efficacy over existing anti-TNF therapies by focusing immune suppression only where needed in the diseased gut. Avaxia plans to use its gut-targeted antibody platform to develop therapeutics to address many other serious diseases such as type 2 diabetes, celiac disease, GI acute radiation syndrome and oral mucositis.
For more than 25 years, SelectHealth has been committed to helping members stay healthy, offering superior service, and providing access to the highest quality of care.
HealthForce is a workplace health company. Our mission is to build enduring customer relationships by delivering world-class health solutions and extraordinary customer service.
Cambridge Healthtech Institute is a Needham Heights, MA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
Carewell is an e-commerce company that provides home health products with discreet packaging and 24/7 service. They aim to improve the lives of caregivers and their loved ones by offering proactive service, compelling content, and expert-vetted products.